Find and Pitch Jounalists, Get Your Story Covered

Tags: gabapentin otolaryngology burning mouth syndrome epistaxis hereditary hemorrhagic telangiectasia

	Profile	Recent Articles on Subject
1	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	This Drug Shows Potential to Stop Migraines Before They Begin - 2 days ago
2	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Novel Agent Reduces Monthly Migraine Days - 12 days ago Gabapentin for Everything; New Brunswick Brain Mystery; Replacing Bits of Old Brain - 27 days ago Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures - about 2 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 5 months ago FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs - 10 months ago
3	Kristen Monaco MedPage Today	FDA Rejects MDMA-Assisted Therapy for PTSD - about 1 month ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - about 2 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 7 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 10 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts New Drug Application for Suzetrigine to Manage Acute Pain - about 2 months ago Teva Launches Generic Formulation of Liraglutide in US - 3 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 6 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 7 months ago FDA Issues Warning Of Antiseizure Medications Causing Rare, Serious Reactions - 10 months ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - 10 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - 10 months ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - 11 months ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Takeda Drug Fails Pivotal Tests in 2 Rare Epilepsies; Path Forward Depends on Regulatory Flexibility - 3 months ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era - 4 months ago
7	Natasha Lomas TechCrunch Journalist. Climber-in-training. Owns cats. Barcelona and London journalismclimbing	Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment - 5 months ago
8	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 6 months ago
9	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Major Congenital Malformation Risk Lower With Several Epilepsy Drugs - 6 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Deaths Linked to a Common Anxiety Drug Have Surged in The UK - 6 months ago

Journalists covering gabapentin